Aquestive Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for AQST

Based on 2 analysts offering 12 month price targets for Aquestive Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell AQST stock?

Based on 2 analysts offering ratings for Aquestive Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
1 analysts 50%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AQST stock forecasts and price targets.

AQST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Bottom 16%
Alliance Global Partners
Bottom 1%
Strong BuyMaintains$7.00+600.00%2022-11-04

1 of 1

AQST vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AQST$1.00$5.50+450.00%Strong Buy
PASG$0.99$8.75+784.73%Strong Buy
IOBT$1.90$10.50+452.63%Strong Buy

Aquestive Therapeutics Stock Forecast FAQ

Is Aquestive Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AQST) stock is to Strong Buy AQST stock.

Out of 2 analysts, 1 (50%) are recommending AQST as a Strong Buy, 1 (50%) are recommending AQST as a Buy, 0 (0%) are recommending AQST as a Hold, 0 (0%) are recommending AQST as a Sell, and 0 (0%) are recommending AQST as a Strong Sell.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.

What is AQST's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AQST price target, the average AQST price target is $5.50, with the highest AQST stock price forecast at $7.00 and the lowest AQST stock price forecast at $4.00.

On average, Wall Street analysts predict that Aquestive Therapeutics's share price could reach $5.50 by Mar 9, 2024. The average Aquestive Therapeutics stock price prediction forecasts a potential upside of 450% from the current AQST share price of $1.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.